BARCLAYS PLC - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 39 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2013,682
+1368100.0%
0.00%
Q2 2023$010.0%0.00%
Q1 2023$010.0%0.00%
Q4 2022$010.0%0.00%
Q3 2022$0
-100.0%
1
-100.0%
0.00%
Q2 2022$10,000
-44.4%
9,671
-12.8%
0.00%
Q1 2022$18,000
-67.9%
11,096
-52.1%
0.00%
Q4 2021$56,00023,186
+2318500.0%
0.00%
Q3 2021$01
-75.0%
0.00%
Q2 2021$0
-100.0%
4
-99.3%
0.00%
Q1 2021$2,000537
+13325.0%
0.00%
Q4 2020$040.0%0.00%
Q3 2020$0
-100.0%
4
-99.8%
0.00%
Q2 2020$6,0002,209
+19981.8%
0.00%
Q1 2020$011
-52.2%
0.00%
Q4 2019$023
-69.7%
0.00%
Q3 2019$0
-100.0%
76
-99.4%
0.00%
Q2 2019$51,000
+218.8%
13,632
+241.2%
0.00%
Q1 2019$16,0003,995
+2693.7%
0.00%
Q4 2018$0
-100.0%
143
-97.3%
0.00%
Q3 2018$46,000
+283.3%
5,280
+417.6%
0.00%
Q2 2018$12,000
-55.6%
1,020
-56.9%
0.00%
Q1 2018$27,000
+58.8%
2,367
+48.5%
0.00%
Q4 2017$17,000
+142.9%
1,594
+246.5%
0.00%
Q3 2017$7,000460
+1079.5%
0.00%
Q2 2017$0
-100.0%
39
-66.1%
0.00%
Q1 2017$2,0000.0%115
-28.1%
0.00%
Q4 2016$2,000160
+661.9%
0.00%
Q3 2016$0210.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$8,746,0001.82%
Telemetry Investments, L.L.C. 263,975$705,0000.97%
CHI Advisors LLC 719,132$1,920,0000.45%
BVF INC/IL 3,678,626$9,822,0000.37%
EcoR1 Capital, LLC 3,579,377$9,557,0000.36%
Orbimed Advisors 8,053,298$21,502,0000.22%
Stonepine Capital Management, LLC 46,886$125,0000.06%
Ikarian Capital, LLC 100,000$267,0000.02%
ALGERT GLOBAL LLC 19,737$53,0000.02%
Windsor Creek Advisors, LLC 14,786$39,0000.01%
View complete list of CORVUS PHARMACEUTICALS INC shareholders